Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Translational Lung Cancer Research|July 23, 2021
Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic reviewZhe Zhang, Sen Yang, Yanfang Ma, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic diseaseAntonin Levy, Lizza E L Hendriks, Thierry Berghmans, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2019
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitorsLizza E L Hendriks, Gerben Bootsma, Jean Mourlanette, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Cancer Letters|January 8, 2026
Automated CT-derived Body Composition Predicts Pathologic Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerYilong Huang, Zhitao Wei, Guanchao Ye, et al.
Clinical Lung Cancer|May 26, 2022
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung CancerSalma K Jabbour, Byoung Chul Cho, Emilio Bria, et al.
Cancer|October 31, 2023
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancerBianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, et al.
JTO Clinical and Research Reports|February 24, 2025
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLCMandy Jongbloed, Valentina Bartolomeo, Martina Bortolot, et al.
Pageof 22